# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-098575
Filing Date
2024-08-19
Accepted
2024-08-19 16:30:30
Documents
88
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K/A | eldn-20231231.htm iXBRL | 10-K/A | 3063060
2 | EX-23.1 | eldn-ex23_1.htm | EX-23.1 | 5709
3 | EX-31.5 | eldn-ex31_5.htm | EX-31.5 | 16032
4 | EX-31.6 | eldn-ex31_6.htm | EX-31.6 | 16275
5 | EX-32.3 | eldn-ex32_3.htm | EX-32.3 | 8356
6 | EX-32.4 | eldn-ex32_4.htm | EX-32.4 | 8199
7 | GRAPHIC | img116206746_0.jpg | GRAPHIC | 868165
8 | GRAPHIC | img116206746_1.jpg | GRAPHIC | 337080
9 | GRAPHIC | img116206746_2.jpg | GRAPHIC | 142341
10 | GRAPHIC | img116206746_3.jpg | GRAPHIC | 119803
| Complete submission text file | 0000950170-24-098575.txt |  | 15985409

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | eldn-20231231.xsd | EX-101.SCH | 1492866
90 | EXTRACTED XBRL INSTANCE DOCUMENT | eldn-20231231_htm.xml | XML | 2710710

Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36620 | Film No.: 241221021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)